Inotek Pharmaceuticals Corporation (the “Company”) today announced the
pricing of its initial public offering of 6,667,000 shares of its common
stock at a price to the public of $6.00 per share for aggregate proceeds
of $40 million, before underwriting discounts.
for Inotek Pharmaceuticals Corporation Announces Pricing of Initial Public Offering of 6,667,000 Shares of Common Stock and 5.0% Convertible Senior Notes due 2020 investment picks